Hans Orlent

2.1k total citations
42 papers, 442 citations indexed

About

Hans Orlent is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Hans Orlent has authored 42 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 19 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Hans Orlent's work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (12 papers). Hans Orlent is often cited by papers focused on Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (12 papers). Hans Orlent collaborates with scholars based in Belgium, Netherlands and United States. Hans Orlent's co-authors include E.J. Kuipers, Jelle Haringsma, Tom G. Moreels, Marcel J. M. Groenen, Solko W. Schalm, Xavier Verhelst, Anja Geerts, Isabelle Colle, Frederik Nevens and Hans Van Vlierberghe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Hans Orlent

41 papers receiving 425 citations

Peers

Hans Orlent

EPIDE

HEPAT

SURGE

GASTR

PHARM

Nóra Sipeki Hungary

Nektarios Dikopoulos Germany

Carmen Monica Preda Romania

Zsuzsanna Vitális Hungary

Allen L. Ginsberg United States

N. Maàmouri Tunisia

Alain Cazier France

Andy Yu United States

Anurag Kumar India

Fuad Hasan Kuwait

Nóra Sipeki Hungary

Hans Orlent

205 ×1.2

EPIDE

191 ×1.3

HEPAT

78 ×0.6

SURGE

20 ×0.3

GASTR

19 ×0.4

PHARM

Citations per year, relative to Hans Orlent Hans Orlent (= 1×) peers Nóra Sipeki

Countries citing papers authored by Hans Orlent

Since Specialization

Citations

This map shows the geographic impact of Hans Orlent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Orlent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Orlent more than expected).

Fields of papers citing papers by Hans Orlent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Orlent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Orlent. The network helps show where Hans Orlent may publish in the future.

Co-authorship network of co-authors of Hans Orlent

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Orlent. A scholar is included among the top collaborators of Hans Orlent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Orlent. Hans Orlent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raevens, Sarah, Christophe Van Steenkiste, Isabelle Colle, et al.. (2024). External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort. JHEP Reports. 6(9). 101149–101149. 1 indexed citations

Busschots, Dana, Cécile Kremer, Rob Bielen, et al.. (2021). A multicentre interventional study to assess blood-borne viral infections in Belgian prisons. BMC Infectious Diseases. 21(1). 708–708. 11 indexed citations

Deprez, Pierre H., Danny De Looze, Marc Ferrante, et al.. (2018). Efficacy and safety of radiofrequency ablation of Barrett’s esophagus in the absence of reimbursement: a multicenter prospective Belgian registry. Endoscopy. 51(4). 317–325. 9 indexed citations

Degré, Delphine, Thomas Sersté, Luc Lasser, et al.. (2017). Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium. PLoS ONE. 12(1). e0170933–e0170933. 8 indexed citations

Bourgeois, Stefan, Hans Van Vlierberghe, Christophe Moreno, et al.. (2017). Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection. BMC Gastroenterology. 17(1). 26–26. 4 indexed citations

Marot, Astrid, Hans Orlent, Thomas Sersté, et al.. (2017). Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clinics and Research in Hepatology and Gastroenterology. 41(6). 656–663. 14 indexed citations

Moreno, Christophe, Luc Lasser, Jean Delwaide, et al.. (2015). Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium. Hepatology. 62(1). 746. 3 indexed citations

Verbeek, Jef, et al.. (2013). Mitochondrial hepatopathy in adults. European Journal of Gastroenterology & Hepatology. 25(8). 892–898. 5 indexed citations

Debonnaire, Philippe, et al.. (2012). One for the road…. European Heart Journal. 34(32). 2500–2500. 1 indexed citations

10.

Orlent, Hans, Hendrik Reynaert, Stefan Bourgeois, et al.. (2011). IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?. PubMed. 74(2). 317–22. 1 indexed citations

11.

Francque, Sven, Stéphane De Maeght, Maciej Adler, et al.. (2011). High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.. PubMed. 74(1). 9–16. 16 indexed citations

12.

Horsmans, Yves, Nancy Thiry, Michael Adler, et al.. (2010). Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. 2 indexed citations

13.

Brenard, R, Pierre Deltenre, Jean Henrion, et al.. (2010). Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. European Journal of Gastroenterology & Hepatology. 22(10). 1253–1259. 39 indexed citations

14.

Orlent, Hans, Isabelle Desombere, Bettina E. Hansen, et al.. (2010). Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon–ribavirin combination therapy after 4 weeks of treatment. European Journal of Gastroenterology & Hepatology. 22(12). 1–1. 1 indexed citations

15.

Verhelst, Xavier, Geert Vanhooren, Ludo Vanopdenbosch, et al.. (2010). Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature. Transplant International. 24(4). e30–e34. 13 indexed citations

16.

Orlent, Hans, Dominik Selleslag, & Stefaan J. Vandecasteele. (2007). Clinical Challenges and Images in GI. Gastroenterology. 132(1). 15–16. 5 indexed citations

17.

Coenegrachts, Kenneth, Hans Orlent, Léon ter Beek, et al.. (2007). Improved focal liver lesion detection: Comparison of single‐shot spin‐echo echo‐planar and superparamagnetic iron oxide (SPIO)‐enhanced MRI. Journal of Magnetic Resonance Imaging. 27(1). 117–124. 26 indexed citations

18.

Orlent, Hans, Bettina E. Hansen, Marc Willems, et al.. (2006). Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial. Journal of Hepatology. 45(4). 539–546. 64 indexed citations

19.

Orlent, Hans, Ron A. A. Mathôt, Eric F.H. van Bommel, et al.. (2005). Peginterferon and Dose-Titrated Ribavirin for Hepatitis C-Associated Nephrotic Membranoproliferative Glomerulonephritis Type 1. Digestive Diseases and Sciences. 50(10). 1804–1806. 6 indexed citations

20.

Orlent, Hans, et al.. (2003). Hepatitis C 2002 guidelines: summary and annotations. Scandinavian Journal of Gastroenterology. 38(0). 105–110. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact